Cargando…

Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials

Thromboprophylaxis for venous thromboembolism is widely used in critically ill patients. However, only limited evidence exists regarding the efficacy and safety of the various thromboprophylaxis techniques, especially mechanical thromboprophylaxis. Therefore, we performed meta-analysis of randomized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jonghanne, Lee, Joo Myung, Lee, Jeong Seok, Cho, Young-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056218/ https://www.ncbi.nlm.nih.gov/pubmed/27709864 http://dx.doi.org/10.3346/jkms.2016.31.11.1828

Ejemplares similares

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Renal function and thromboprophylaxis in critically ill patients
por: Scholey, Gareth M, et al.
Publicado: (2010)

Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
por: Piagnerelli, Michaël, et al.
Publicado: (2020)

Pharmacological thromboprophylaxis and epidural anaesthesia
por: Harsoor, SS, et al.
Publicado: (2012)

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?
por: Gurjar, Mohan
Publicado: (2014)

Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
por: Jonmarker, Sandra, et al.
Publicado: (2020)

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection
por: Kummer, R.L., et al.
Publicado: (2021)

Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
por: de Montmollin, Etienne, et al.
Publicado: (2021)

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit
por: Lauzier, François, et al.
Publicado: (2014)

Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
por: Zhang, Cong, et al.
Publicado: (2020)

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

Is delaying pharmacological thromboprophylaxis associated with thromboembolic complications?
por: Padim, P, et al.
Publicado: (2015)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial
por: Arabi, Yaseen M, et al.
Publicado: (2016)

What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
por: Cauchie, Philippe, et al.
Publicado: (2021)

Erratum to: Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2016)

Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis
por: Li, Guowei, et al.
Publicado: (2016)

Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection
por: Fattorutto, Maurizio, et al.
Publicado: (2021)

Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Hafiz, Awatif, et al.
Publicado: (2023)

Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study
por: Yhim, Ho-Young, et al.
Publicado: (2017)

Pharmacology of the critically ill
por: Grounds, R M
Publicado: (2002)

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
por: MacDougall, Kira, et al.
Publicado: (2020)

The efficacy and safety of pharmacologic thromboprophylaxis following caesarean section: A systematic review and meta-analysis
por: Yang, Rui, et al.
Publicado: (2018)

Systematic Review and Meta-analysis of the Additional Benefit of Pharmacological Thromboprophylaxis for Endovenous Varicose Vein Interventions
por: Turner, Benedict R. H., et al.
Publicado: (2023)

Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
por: Lim, So Yeon, et al.
Publicado: (2013)

Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis
por: Burry, Lisa D., et al.
Publicado: (2021)

Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis
por: Horner, Daniel, et al.
Publicado: (2019)

Post-hepatectomy venous thromboembolism: a systematic review with meta-analysis exploring the role of pharmacological thromboprophylaxis
por: Karunakaran, Monish, et al.
Publicado: (2022)

Pharmacological Thromboprophylaxis after Major Abdominal Surgery: Should the Duration be Individualized?
por: Papageorgopoulou, Chrysanthi, et al.
Publicado: (2022)

High level of venous thromboembolism in critically ill trauma patients despite early and well-driven thromboprophylaxis protocol
por: Hamada, S. R., et al.
Publicado: (2017)

A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data
por: Alrashed, Ahmed, et al.
Publicado: (2022)

Direct oral anticoagulants for extended thromboprophylaxis in medically ill patients: meta-analysis and risk/benefit assessment
por: Al Yami, Majed S, et al.
Publicado: (2018)

Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
por: Raskob, Gary E., et al.
Publicado: (2022)

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
por: Ferrandis, R., et al.
Publicado: (2023)

Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
por: Alavi-Darazam, Ilad, et al.
Publicado: (2022)

Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach
por: Sahle, Berhe W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_84gebpv42k7ribeqdupoo9ugj7